Open consultations

19 results

  • MSAC Consultation Survey - Application 1659.1

    MSAC application 1659.1 Catheter-based renal denervation for uncontrolled elevated systolic blood pressure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1782.1

    MSAC application 1782.1 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with estrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised elacestrant. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1795

    MSAC application 1795 Positron emission tomography / computed tomography (PET/CT) dopaminergic imaging for evaluating Parkinsonism. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1793

    MSAC application 1793 Diagnostic genomic testing for fetal anomalies Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1786 - resubmission

    A further period of consultation is open on application 1786 – FreeStyle Libre 2 continuous glucose monitoring (CGM) System for people with insulin-dependent type 2 diabetes, gestational diabetes and type 3c diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. ... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1812

    MSAC application 1812 Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1818

    MSAC Application 1818 – Expansion of specialist supervision criteria for MBS and PBS items for integrated, closed-system, extracorporeal photopheresis and methoxsalen (UVADEX®) for the treatment of Cutaneous T-Cell Lymphoma and chronic Graft Versus Host Disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1785 - resubmission

    A further period of consultation is open on application 1785 – Dexcom ONE+ Continuous Glucose Monitoring (CGM) System for people with insulin-dependent type 2 diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. MSAC previously considered application... More
    Closes 12 June 2026

  • MSAC Consultation Survey - Application 1823

    MSAC application 1823 177 Lutetium PSMA-617 for prostate specific membrane antigen (PSMA)-positive, taxane-naïve patients with metastatic castrate resistant prostate cancer (mCRPC). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1822

    MSAC application 1822 F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for evaluation of complex infection. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1825

    MSAC application 1825 Transcranial Doppler bubble test for patent foramen ovale. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1821

    MSAC application 1821 Testing for Chromogranin A in patients with neuroendocrine neoplasms. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1826

    MSAC application 1826 N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) testing to support management of patients with heart failure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1820

    MSAC application 1820 In situ hybridisation (ISH) testing of tumour tissue to detect viral genomes (EBV and HPV). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1738.1

    MSAC application 1738.1 Investigations to support the use of PBS subsidised lecanemab in people with mild cognitive impairment and mild dementia due to Alzheimer’s disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Closes 10 July 2026

  • MSAC Consultation Survey - Application 1827

    MSAC application 1827 Testing for hepatitis B virus (HBV) and hepatitis B virus surface antigen (HBsAg) to support the use of PBS subsidised bepirovisen in people with chronic hepatitis B (CHB). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Closes 10 July 2026

  • CEEU/HTA Updates

    Receive regular HTA Engage e-newsletters for updates on HTA activities and announcements from the CEEU, including open consultation dates for PBAC and MSAC meeting agenda items. More
    Closes 1 June 2028

  • MSAC Updates

    Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates. More
    Closes 1 June 2028

  • PBAC Updates

    Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes. More
    Closes 1 June 2028
19 results. Page 1 of 1